Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/1999
10/07/1999CA2324421A1 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999CA2324060A1 Methods and compounds for modulating nuclear receptor activity
10/07/1999CA2323833A1 Compositions and methods for the identification of lung tumor cells
10/07/1999CA2323524A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof
10/07/1999CA2320491A1 Stimulated monocyte derived cells, their preparation and uses
10/07/1999CA2320260A1 Method of inhibiting membrane-type matrix metalloproteinase
10/07/1999CA2295049A1 Methods to potentiate intravenous estramustine phosphate
10/06/1999EP0947583A2 DNA fragments activated in expression of melanoma inhibiting protein (MIA)
10/06/1999EP0947522A2 Process for the preparation of oenotheine B from Epilobium Parviflorum
10/06/1999EP0947514A1 Novel phenanethridinium derivatives
10/06/1999EP0947511A1 Derivatives of phenoxy acetic acid and of phenoxymethyl tetrazole having antitumor activity
10/06/1999EP0947503A1 6,8-Dimethylmercaptooctanoic acid derivatives substituted on 6-S and/or 8-S by the 3-methylthiopropanoyl radical and pharmaceutical compositions for the treatment of cancerous tumours
10/06/1999EP0947222A2 Method of activating photosensitive agents
10/06/1999EP0946880A1 Method for diagnosis and therapy of hodgkin lymphomas
10/06/1999EP0946733A1 Hsv/aav hybrid amplicon vectors
10/06/1999EP0946722A1 Human apoptosis-related calcium-binding protein
10/06/1999EP0946719A1 Guanine exchange factor of rho gtpase and nucleic acid encoding it
10/06/1999EP0946587A2 New amide compounds
10/06/1999EP0946586A1 Aminosterol ester compounds
10/06/1999EP0946567A1 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
10/06/1999EP0946566A1 Pro-drugs and counterparts of camptothecin, their application as medicines
10/06/1999EP0946565A1 Method and device for production of lyophilized hydrochloride-1ss, 10ss-epoxy-13-dimethylamino-guaia-3(4)-en-6,12-olide
10/06/1999EP0946554A1 Fused bicyclic pyrimidine derivatives
10/06/1999EP0946541A1 Quinolines and their therapeutic use
10/06/1999EP0946523A1 Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
10/06/1999EP0946512A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/06/1999EP0946509A1 Novel heterocyclically substituted benzamides and their use in fighting diseases
10/06/1999EP0946185A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
10/06/1999EP0946182A1 17$g(a)-DIHYDROEQUILENIN FOR USE AS A MEDICAL ANTIOXIDANT
10/06/1999EP0946165A1 Integrin antagonists
10/06/1999EP0946164A1 Integrin antagonists
10/06/1999EP0839133B1 4,9-ethano-benzo(f)isoindole derivatives as farnesyl transferase inhibitors
10/06/1999EP0722326A4 Highly sulfated maltooligosaccharides with heparin-like properties
10/06/1999EP0597018B1 Glycosidation reaction
10/06/1999EP0517815B1 AN IgG-1 HUMAN MONOCLONAL ANTIBODY REACTIVE WITH AN HIV-1 GLYCOPROTEIN AND METHOD OF USE
10/06/1999CN1230989A Embryonic or stem-like cell lines produced by cross species nuclear transplantation
10/06/1999CN1230960A Intermediates for preparation of duocarmycin SA and derivatives thereof, and process for production of intermdiates
10/06/1999CN1230948A Pyranoindole and carbazole inhibitors of COX-2
10/06/1999CN1230887A Reducing toxic effects of carboplatin using dithioethers
10/06/1999CN1230542A Sidechain-bearing taxanes
10/06/1999CN1230435A Composite glossy ganoderma spore powder
10/06/1999CN1230407A Method and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia
10/05/1999US5962707 19-nor-vitamin D3 compounds with calcemic activity
10/05/1999US5962698 Plasminogen activator inhibitor
10/05/1999US5962672 Antisense modulation of RhoB expression
10/05/1999US5962666 Polynucleotide or its complement which codes for enzyme involved in bacterial protein synthesis; for diagnosis and treatment of chlamydia infections such as urogenital disorders and vision defects; bactericides
10/05/1999US5962660 Compound which suppresses selectin-mediated cellular adhesion; for stable antiinflammatory agents with better bioavailability and greater activity which are easier to synthesize
10/05/1999US5962529 Metalloproteinase inhibitors
10/05/1999US5962527 Method and composition for treating cancers
10/05/1999US5962521 Prostate glands disorders
10/05/1999US5962504 Activator of protein kinase; anticancer agent
10/05/1999US5962495 Estrogen sensitive diseases; breast cancer; prostate tumors
10/05/1999US5962479 Psychological and nervous sytem disorders
10/05/1999US5962471 Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids
10/05/1999US5962458 Angiogenesis inhibitors, anticancer agents, antidiabetic agents, skin disorders, autoimmune diseases, antiinflammatory agents, vision defects
10/05/1999US5962444 Hormone inhibitor; hormone replacement therapy
10/05/1999US5962437 Hepatitis, herpes and aida virus
10/05/1999US5962431 Method of treating papillomavirus using 2',5'-oligoadenylate
10/05/1999US5962426 Hybrid
10/05/1999US5962422 Inhibition of selectin binding
10/05/1999US5962415 Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppressant and methods of use thereof
10/05/1999US5962411 Human growth hormone variants and methods of administering same
10/05/1999US5962410 Fungicides, antiprotozoa agent
10/05/1999US5962409 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
10/05/1999US5962331 Cell growth regulator
10/05/1999US5962312 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders
10/05/1999US5962300 Polynucleotide which encodes a polypeptide tumor suppressor; for diagnosis, prevention, and treatment of cancer, eczema, psoriasis, psoriasis, scleroderma, dermatitis, skin atrophy, and other skin disorders; anticarcinogenic agents
10/05/1999US5962265 A polypeptide is described which is expressed at a particularly high level in tissues of the human immune system.
10/05/1999US5962231 Human glutathione-S-transferase
10/05/1999US5962216 Tumor-activated prodrug compounds and treatment
10/05/1999US5961978 Therapeutically useful peptides and peptide fragments
10/05/1999US5961969 Enhancing natural killer cell cytotoxicity.
10/05/1999US5960792 Device for aerosolized delivery of peptide drugs
10/05/1999CA2158147C Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
09/1999
09/30/1999WO1999049316A2 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer
09/30/1999WO1999049065A1 Antisense modulation of human mdm2 expression
09/30/1999WO1999049055A1 Human casb12 polypeptide, a serine protease
09/30/1999WO1999049038A2 Human calcium-binding proteins
09/30/1999WO1999049037A2 Protein phosphatase-related molecules
09/30/1999WO1999049033A1 Casb414: antigen overexpressed in several tumors
09/30/1999WO1999049030A1 Compounds related to pap-1
09/30/1999WO1999049027A1 Methods for prevention and treatment of cancer
09/30/1999WO1999049025A2 Human vault rna
09/30/1999WO1999048925A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses
09/30/1999WO1999048917A2 Formulation having a papilloma virus-specific protein, and the production and use thereof
09/30/1999WO1999048916A2 Hypoxia-inducible human genes, proteins, and uses thereof
09/30/1999WO1999048894A1 Novel cephalotaxane derivatives and process for their preparation
09/30/1999WO1999048889A1 Halimide, a cytotoxic marine natural product, and derivatives thereof
09/30/1999WO1999048881A1 Metalloproteinase inhibitors
09/30/1999WO1999048868A2 Heterocyclic classes of compounds for the modulating tyrosine protein kinase
09/30/1999WO1999048860A1 Anti-tumour agents
09/30/1999WO1999048857A1 Anti-tumour agents
09/30/1999WO1999048536A2 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo
09/30/1999WO1999048535A1 Formulations for protection of peg-interferon alpha conjugates
09/30/1999WO1999048527A1 Apo-2 ligand-anti-her-2 antibody synergism
09/30/1999WO1999048518A2 Medicament for preventing or treating papilloma virus-specific tumors
09/30/1999WO1999048515A1 Trimeric antigenic o-linked glycopeptide conjugates, methods of preparation and uses thereof
09/30/1999WO1999048503A1 Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate
09/30/1999WO1999048496A1 Therapy of estrogen-associated disorders
09/30/1999WO1999048495A1 Benzoates derivatives for inhibiting angiogenesis
1 ... 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 ... 2211